Biography

Prof. Ronald B. Moss

Ansun BioPharma Inc., USA

Executive Vice President


Email: shotdoc92130@yahoo.com


Qualifications


1982-1988 M.D., The Chicago Medical School, Medicine

1978-1982 B.A., State University of New York, Psychology/Bioethics


Publications (selected)

  1. Guzmán-Suarez, BB, Buckley, MM, Gilmore, E.T., Vocca, E, Moss, R., Marty, FM, Baden,LR, Issa, NC, Koo S.,Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients, Transplant Infectious Disease, 2012.
  2. Chen, YB, Driscoll, j., McAfee, SL Spitzer, TR, Rosenberg, E, Sanders, R., Moss R, Fang, F, Marty, F, Treatment of Parainfluenza 3 Infection with DAS181 in a Patient After Allogeneic Stem Cell Transplantation, Journal of Clinical Infectious Disease, 2011.
  3. Moss RB, Steigbigel, R., Sanders, R. L., F. Fang, Emerging Challenges in the Treatment of Influenza and Parainfluenza in Transplant Patients, Advances in Virology, July, 2011.
  4. Moss, RB, Davey, RT; Steigbigel, RT, Fang F., Targeting Pandemic Influenza: A Primer on Influenza Antivirals and Drug Resistance, J Antimicrob Chemother. 2010 doi:10.1093/jac/dkq100.
  5. Triana-Baltzer, Gallen., Gubareva, L,, Klimov, A, Wurtman, D., Moss, RB, , Belshe, RB, Fang Fang, Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS One 2009; 4: e7838.
  6. Triana-Baltzer, Gallen., Gubareva, L, Nicholls, JM, Belser, JA, Mishin, VP, Pearce, MB,, Chen, LM, Chan, RWY, Chan, MCW, Hedlund, M, Moss, RB, Katz, JM, Tumpey, TM, Fang, F, Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS One 2009 4: e7788.
  7. Moss, RB, Prospects for Control of Emerging Infectious Diseases with Plasmid DNA Vaccines, Journal of Immune Based Therapies and Vaccines, 2009, 7:3 7 September 2009.
  8. Jacobson MA, Adler SP, Sinclair E, Black D, Smith A, Chu A, Moss RB, Wloch MK, A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain). Vaccine, 27 10 1540-1548, March 2009.
  9. Soo Hoo W, Jensen E, Saadat A, Nieto D, Moss R, Carlo D, Moll T. Vaccination with Cell Immunoglobulin Mucin-1 Antibodies and Inactivated Influenza Enhances Vaccine-Specific Lymphocyte Proliferation, IFN-Gamma Production, and Cross-Strain Reactivity, Clin Exp Immunology, 2006, July; 145/(1):123-9.
  10. Encinas JA, Janssen EM, Weiner DB, Calarolata SA, Nieto D, Moll T, Carlo DJ, Moss RB, Anti-TIM-1 Antibody Decreases Th2 Airway Inflammation in a Mouse Model of Asthma. Journal of Allergy and Clinical Immunology, 116, 1343-9, 2006.
  11. Ayash-Roshkovsky M, Barkow G., Davis HL, Moss RB, Bartholomew R, Bentwich Z, Enhanced HIV-1 Specific Immune Responses by CpG ODN and HIV-1 Immunogen-Pulsed Dendritic Cells Confers Protection in the Trimera Murine Model of HIV-1 Infection. FASEB Journal, April 15, 2005.
  12. Jiang J, Patrick A, Moss R, Rosenthal K, CD8+ T-Cell Mediated Cross Clade Protection in the Genital Track Following Intranasal Immunization with an Inactivated Human Immunodeficiency Virus Antigen Plus CpG Oligonucleotides. Journal of Virology, 79, 2005, 309-400.
  13. Moss RB, Moll T, El-Kalay M, Kohne C, Soo Hoo E, Encinas J, Carlo DJ, Th1/Th2 Cells in Inflammatory Disease States: Therapeutic Implications. Expert Opin. Biol. Ther, 4, 12, 1187-96, 2004.
  14. Silvera, et al., Moss RB, and Lewis MG, Vaccination with Gp120-Depleted HIV-1 Plus Immunostimulatory CpG Oligodeoxynucleotides in Incomplete Freund’s Adjuvant Stimulates Cellular and Humoral Immunity in Rhesus Macaques. Vaccine, 23, 2004, 827-39.
  15. Hong IC, Mullen P, Precht A, Khanna A, Li M, Behling C, Lopez V, Chiou H Moss RB, Hart M, Non-Viral Human IL-10 Gene Expression Reduces Acute Rejection in Heterotopic Auxiliary Liver Transplantation in Rats. Microsurgery, 23, 432-6,2003.
  16. Blower SM, Moss RB, Fernandez-Cruz E, Calculating the Potential Epidemic-Level Impact of Therapeutic Vaccination on the San Francisco HIV Epidemic. AIDSCIENCE, 10/31/2003.
  17. Valdez H, Mitsuyasu R, Landay A, Sevin AD, Chan ES, Spritzler J, Kalams SA, Pollard RB, Fahey J, Fox L, Namkung A, Estep S, Moss R, Sahner D, Lederman MM, Interleukin-2 Increases CD4+ Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s. Journal of Infectious Diseases 15;187(2):320-5, 2003.
  18. Moss RB, Brandt C, Giermakowska WK, Savary JR, Theofan G, Zanetti M, Carlo DJ, Wallace MR, HIV-Specific Immunity During Structured Antiviral Drug Treatment Interruption. Vaccine 21(11-12):1066-71, 2003.
  19. Banaszczyk MG, Carlo AT, Millan V, Lindsey A, Moss R, Carlo DJ, Propofol Phosphate, a Water-Soluble Propofol Prodrug: In Vivo Evaluation, Anesth Analg 95(5):1285-92, 2002.
  20. Moss RB, Wallace MR, Steigbigel RT, Morrison SA, Giermakowska WK, Nardo CJ, Diveley JP, Carlo DJ, Predictors of HIV-Specific Lymphocyte Proliferative Immune Responses Induced by Therapeutic Vaccination. Clinical Experimental Immunology 128:359-364, 2002.
  21. Dumais N, Patrick A, Moss RB, Davis HL, Rosenthal KL, Mucosal Immunization with Inactivated Human Immunodeficiency Virus plus CpG Oligodeoxynucleotides Induces Genital Immune Responses and Protection Against Intravaginal Challenge. Journal Infectious Diseases 186(8):1098-105, 2002.
  22. Aysah-Rashkovsky M, Weisman Z, Diveley J., Moss RB, Bentwich Z, Borkow G, Generation of Th1 Immune Responses to Inactivated, Gp120-Depleted HIV-1 in Mice with a Dominant Th2 Biased Immune Profile Via Immunostimulatory Oligonucleotides-Relevance to AIDS Vaccines in Developing Countries. Vaccine 20:2684-2692, 2002.
  23. Moss RB, Wallace MR, Steibigel RT, Morrison SA, Giermakowska WK, Nardo CJ, Diveley JP, Carlo DJ, Predictors of HIV-Specific Lymphocyte Proliferative Immune Responses Induced by Therapeutic Vaccination. Clinical Experimental Immunology 128:359-364, 2002.
  24. Moss RB, Savary JR, Diveley JP, Jensen F, Carlo DJ, Maternal and Newborn Immunization with a Human Immunodeficiency Virus-1 Immunogen in a Rodent Model. Immunology 106:549-553, 2002.

Profile Details

NULL

Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top